FI873222A0 - Medel foer behandling av hemofili a, som aer resistent mot faktor viii, och foerfarande foer framstaellning av detta medel. - Google Patents

Medel foer behandling av hemofili a, som aer resistent mot faktor viii, och foerfarande foer framstaellning av detta medel.

Info

Publication number
FI873222A0
FI873222A0 FI873222A FI873222A FI873222A0 FI 873222 A0 FI873222 A0 FI 873222A0 FI 873222 A FI873222 A FI 873222A FI 873222 A FI873222 A FI 873222A FI 873222 A0 FI873222 A0 FI 873222A0
Authority
FI
Finland
Prior art keywords
medel
factor viii
hemofili
detta
resistent
Prior art date
Application number
FI873222A
Other languages
English (en)
Other versions
FI873222A (fi
FI87044C (fi
FI87044B (fi
Inventor
Norbert Heimburger
Karlheinz Wenz
Wilfried Wormsbaecher
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6305910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI873222(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI873222A0 publication Critical patent/FI873222A0/fi
Publication of FI873222A publication Critical patent/FI873222A/fi
Application granted granted Critical
Publication of FI87044B publication Critical patent/FI87044B/fi
Publication of FI87044C publication Critical patent/FI87044C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI873222A 1986-07-24 1987-07-22 Foerfarande foer framstaellning av ett medel med vilket man kan behandla hemofili a, som aer resistent mot faktor viii FI87044C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3625090 1986-07-24
DE19863625090 DE3625090A1 (de) 1986-07-24 1986-07-24 Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung

Publications (4)

Publication Number Publication Date
FI873222A0 true FI873222A0 (fi) 1987-07-22
FI873222A FI873222A (fi) 1988-01-25
FI87044B FI87044B (fi) 1992-08-14
FI87044C FI87044C (fi) 1992-11-25

Family

ID=6305910

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873222A FI87044C (fi) 1986-07-24 1987-07-22 Foerfarande foer framstaellning av ett medel med vilket man kan behandla hemofili a, som aer resistent mot faktor viii

Country Status (12)

Country Link
US (1) US5091363A (fi)
EP (1) EP0255651B1 (fi)
JP (1) JP2535547B2 (fi)
AT (1) ATE73673T1 (fi)
AU (1) AU607924B2 (fi)
CA (1) CA1321139C (fi)
DE (2) DE3625090A1 (fi)
DK (1) DK166652B1 (fi)
ES (1) ES2037035T3 (fi)
FI (1) FI87044C (fi)
GR (1) GR3004868T3 (fi)
PT (1) PT85386B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03215430A (ja) * 1990-01-19 1991-09-20 Kita Kiyoshi 関節腔抗凝固剤
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
CA2090738C (en) * 1993-02-24 1996-05-21 Hema-Quebec Use of paf
US7582712B1 (en) 2008-05-09 2009-09-01 Formosa Plastics Corporation, U.S.A. Alpha-olefins polymerization catalyst
CN108226540B (zh) * 2018-02-08 2020-07-03 武汉市长立生物技术有限责任公司 一种鞣花酸试剂及其配制方法与活化部分凝血活酶时间测定试剂、aptt试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2550011C2 (de) * 1975-11-07 1982-11-25 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines antihämophilen Mittels
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
JPS5770814A (en) * 1980-10-17 1982-05-01 Isamu Horikoshi Oral preparation of blood clotting eighth factor
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
EP0148843B2 (en) * 1983-03-21 1994-05-04 Novo Nordisk A/S A concentrate of the antihemophilic factor viii and a process for producing it
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
US4610880A (en) * 1983-06-27 1986-09-09 Queen's University At Kingston Composition for controlling hemophilia in mammals
US4536392A (en) * 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing

Also Published As

Publication number Publication date
DK384687D0 (da) 1987-07-23
US5091363A (en) 1992-02-25
EP0255651A3 (en) 1989-10-11
DE3777482D1 (de) 1992-04-23
ATE73673T1 (de) 1992-04-15
PT85386A (pt) 1988-07-29
JPS6345224A (ja) 1988-02-26
ES2037035T3 (es) 1993-06-16
CA1321139C (en) 1993-08-10
EP0255651B1 (de) 1992-03-18
DE3625090A1 (de) 1988-01-28
FI873222A (fi) 1988-01-25
EP0255651A2 (de) 1988-02-10
AU607924B2 (en) 1991-03-21
DK384687A (da) 1988-01-25
FI87044C (fi) 1992-11-25
PT85386B (pt) 2001-05-31
JP2535547B2 (ja) 1996-09-18
FI87044B (fi) 1992-08-14
GR3004868T3 (fi) 1993-04-28
AU7604987A (en) 1988-01-28
DK166652B1 (da) 1993-06-28

Similar Documents

Publication Publication Date Title
NO871361L (no) Fremgangsmaate for redusering av vaesketap i sementblandinger som kan inneholde betydelige saltkonsentrasjoner.
SE8206168D0 (sv) Preparations and process for preparation thereof
DK0622990T3 (da) Carbonatholdige hydroxyapatitpræparater og deres anvendelser
SE8403871D0 (sv) Kemisk forening, anvendbar som mellanprodukt vid framstellning av vissa cyanoguanidinderivat
FI873222A (fi) Medel foer behandling av hemofili a, som aer resistent mot faktor viii, och foerfarande foer framstaellning av detta medel.
MX165470B (es) Agentes de carbonatacion de aminoazucares y preparacion
FI843909L (fi) Foerfarande foer pastoerisering av plasma eller av koncentrat av blodkoaguleringsfaktorerna ii, vii, ix och x.
FI92389B (fi) Halogenoitujen imidien valmistusmenetelmä, niitä sisältävät koostumukset ja niiden käyttö tulenkestäviksi tekevinä aineina
SE8101270L (sv) Nya derivat av lignosulfonsyra samt framstellning och anvendning derav
ATE32880T1 (de) Verfahren zur herstellung von anthrachinon.
ATE111891T1 (de) Verfahren zur herstellung von 3- nitrobenzolsulfonsäurechlorid.
BR8706782A (pt) Banhos para o polimento quimico de superficies de aco inoxidavel e processo para o polimento de uma superficie de aco inoxidavel
ES551363A0 (es) Procedimiento para fabricar carbonato de sodio anhidro denso
NO911466D0 (no) Fremgangsmaate for fjerning av kolesterol i eggeplomme.
ATE1239T1 (de) Verfahren zur herstellung von 4-amino-5-chlor-1-phenyl-pyridazon-(6).
ATE76868T1 (de) Verfahren zur herstellung von 1,2-disulfonverbindungen.
SE8100341L (sv) Antitumormedel och kompositioner pa basis derav samt forfarande for framstellning av dessa kompositioner
SE8306946L (sv) Framstellning av aryloxibensoesyror som innehaller en sulfonamidgrupp
FI855093A (fi) Foerfarande foer framstaellning av en blandpigment innehaollande titandioxid och kalciumfluorid och anvaendning daerav som papperspigment.
JPS5252197A (en) Method for preparating sulfonate containing nitrogen
JPS6442480A (en) Sulfonamide based compound or its salt, production thereof and herbicide containing said compound or salt as active ingredient

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: CENTEON PHARMA GMBH

FG Patent granted

Owner name: AVENTIS BEHRING GMBH

MA Patent expired